Exercise fights age-related muscle loss, but adherence decides how much you get back

Ageing brings a progressive decline in skeletal muscle mass and strength, and when that decline crosses into sarcopenia it erodes independence and quality of life. Exercise is the obvious countermeasure, but trials in older adults with sarcopenia have used wildly different programmes, which leaves open the question of whether the amount and structure of exercise matters as much as the fact of doing it. This review set out to answer exactly that, asking how different exercise volumes affect physical function, body composition and quality of life, and whether following the American College of Sports Medicine's recommendations makes a measurable difference to the outcome.

The authors systematically searched PubMed, Embase, Web of Science and the Cochrane Library for randomised controlled trials of exercise interventions in older adults with sarcopenia, covering studies published up to 28 February 2026. Study quality was assessed with the Cochrane Risk of Bias tool before the results were pooled statistically. Crucially, they ran subgroup analyses splitting trials by how closely the exercise programmes adhered to American College of Sports Medicine guidelines, then checked the robustness of their pooled results with sensitivity analyses and tested for publication bias using funnel plots and Egger's regression test.

Compared with control groups, exercise significantly improved handgrip strength, with a standardised mean difference of 0.47, and gait speed, at 0.70. Walking test performance improved by a standardised mean difference of -0.73, skeletal muscle index rose by 0.48, and body fat percentage fell by -0.62, all statistically significant. The subgroup analyses carried the headline finding: improvements in handgrip strength, gait speed, walking performance, skeletal muscle index, bone mineral density, and health status and quality of life were all significantly greater in the high-adherence group than in the low-adherence group. Quality-of-life gains in particular depended on high adherence to the guidelines.

That exercise helps older adults with sarcopenia is not new; this pooling of randomised trials confirms it across strength, mobility and body composition at once. What it adds is the adherence signal: following a properly structured programme built on established guidelines appears to amplify every outcome, and quality of life may not improve at all without it. The authors themselves urge caution, noting that confirmation requires large-scale randomised trials with longer follow-up. Open questions remain about the optimal exercise volume, how long the benefits persist, and whether the adherence effect reflects the programmes themselves or the kind of people able to stick with them.

For anyone watching strength, walking speed or muscle mass decline with age, this is a reason for genuine optimism: structured exercise moved every major marker of physical function and body composition in the right direction in these pooled trials. It is also a reason to take programme design and consistency seriously, since the people who adhered closely to established guidelines saw larger improvements across the board, and the quality-of-life benefit appeared only with that high adherence. The honest reading is that showing up matters, but showing up consistently to a well-designed programme matters more. None of this fixes the dose question, which the field still owes older adults an answer on.